Vı́tězslav Křı́ž
- Co-authors
- Vladimír KořínekMichael WelshCecilia LindholmCecilia AnnerénVı́tězslav BryjaLívia EiselleováJakub NeradilAleš Hampl
- Topics
- Wnt/β-catenin signaling in development and cancer (8 papers)Pancreatic function and diabetes (8 papers)Pluripotent Stem Cells Research (6 papers)
- Partner nations
- CzechiaSwedenUnited States
In The Last Decade
Vı́tězslav Křı́ž
26 papers receiving 740 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 545
- Oncology 127
- Surgery 118
- Genetics 103
- Cell Biology 97
Countries citing papers authored by Vı́tězslav Křı́ž
This map shows the geographic impact of Vı́tězslav Křı́ž's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vı́tězslav Křı́ž with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vı́tězslav Křı́ž more than expected).
Fields of papers citing papers by Vı́tězslav Křı́ž
This network shows the impact of papers produced by Vı́tězslav Křı́ž. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vı́tězslav Křı́ž. The network helps show where Vı́tězslav Křı́ž may publish in the future.
Co-authorship network of co-authors of Vı́tězslav Křı́ž
This figure shows the co-authorship network connecting the top 25 collaborators of Vı́tězslav Křı́ž. A scholar is included among the top collaborators of Vı́tězslav Křı́ž based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vı́tězslav Křı́ž. Vı́tězslav Křı́ž is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 11 | |
| 5 | 31 | |
| 6 | 3 | |
| 7 | 49 | |
| 8 | 41 | |
| 9 | 12 | |
| 10 | 19 | |
| 11 | 60 | |
| 12 | 48 | |
| 13 | 30 | |
| 14 | 24 | |
| 15 | 8 | |
| 16 | 1 | |
| 17 | 13 | |
| 18 | 20 | |
| 19 | 15 | |
| 20 | 50 |
About Vı́tězslav Křı́ž
Vı́tězslav Křı́ž is a scholar working on Cell Biology, Molecular Biology and Toxicology, having authored 26 papers that have together received 755 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (8 papers), Pancreatic function and diabetes (8 papers) and Pluripotent Stem Cells Research (6 papers). The work is most often cited by research in Molecular Biology (545 citations), Cell Biology (97 citations) and Oncology (127 citations). Vı́tězslav Křı́ž has collaborated with scholars based in Czechia, Sweden and United States. Frequent co-authors include Vladimír Kořínek, Michael Welsh, Cecilia Lindholm, Cecilia Annerén, Vı́tězslav Bryja, Lívia Eiselleová, Jakub Neradil, Aleš Hampl, Petr Dvořák and Boris Tichý. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.